159 related articles for article (PubMed ID: 23942221)
21. Adoption of surgical innovations: factors influencing use of sentinel lymph node biopsy for breast cancer.
Wright FC; Gagliardi AR; Fraser N; Quan ML
Surg Innov; 2011 Dec; 18(4):379-86. PubMed ID: 21742665
[TBL] [Abstract][Full Text] [Related]
22. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
23. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
24. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
25. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
26. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
[TBL] [Abstract][Full Text] [Related]
28. Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer.
Li P; Yang C; Zhang J; Chen Y; Zhang X; Liang M; Huang N; Chen Y; Wang K
Oncologist; 2023 Aug; 28(8):e591-e599. PubMed ID: 36929946
[TBL] [Abstract][Full Text] [Related]
29. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
30. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
31. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
32. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
[TBL] [Abstract][Full Text] [Related]
33. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
35. Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes.
Nurgalieva ZZ; Franzini L; Morgan RO; Vernon SW; Du XL
Am J Manag Care; 2013 Oct; 19(10):805-10. PubMed ID: 24304159
[TBL] [Abstract][Full Text] [Related]
36. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
37. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
Kantor O; Pesce C; Liederbach E; Wang CH; Winchester DJ; Yao K
Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828
[TBL] [Abstract][Full Text] [Related]
38. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
Schwartz GF
Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
[TBL] [Abstract][Full Text] [Related]
39. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
40. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.
Shah DR; Canter RJ; Khatri VP; Bold RJ; Yang AD; Martinez SR
Ann Surg Oncol; 2013 Jan; 20(1):24-30. PubMed ID: 23054103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]